CNS inflammatory vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in COVID-19
Open Access
- 1 September 2020
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology Neuroimmunology & Neuroinflammation
Abstract
A 44-year-old right-handed woman reported a gradual onset of right hand incoordination seven days after the onset of minor respiratory symptoms and pruritus due to COVID-19 infection. Over 48 hours, the patient developed word-finding difficulties and progression in right arm weakness leading to presentation to the emergency department as a suspected stroke.This publication has 7 references indexed in Scilit:
- Neurological manifestations and neuro‐invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2European Journal of Neurology, 2020
- Endothelial cell infection and endotheliitis in COVID-19The Lancet, 2020
- MRI features of demyelinating disease associated with anti-MOG antibodies in adultsJournal of Neuroradiology, 2019
- Perivascular enhancement in anti-MOG antibody demyelinating disease of the CNSJournal of Neurology, Neurosurgery & Psychiatry, 2018
- Clinical presentation and prognosis in MOG-antibody disease: a UK studyBrain, 2017
- Angiotensin‐converting enzyme 2 in the brain: properties and future directionsJournal of Neurochemistry, 2008
- What is the blood–brain barrier (not)?Trends in Immunology, 2007